Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 0.73 |
| ▸ | HTT | P42858 | 3/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 4/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | CASP1 | P29466 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | PLEC | Q15149 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2092431 | 0.86 | MAPT (0.67) | MAPTHTTHRH3MEN1KMT2A | |
| SCHEMBL2065837 | 0.85 | MAPT (1.00) | MAPTHTTHRH3MEN1KMT2A | |
| SCHEMBL2088459 | 0.85 | MAPT (0.64) | MAPTHTTHRH3MEN1KMT2A | |
| SCHEMBL2093052 | 0.83 | MAPT (0.61) | MAPTHTTHRH3MEN1KMT2A | |
| SCHEMBL5077122 | 0.83 | MAPT (0.61) | MAPTHTTHRH3MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL15329323 | 0.82 | MAPT (0.94) | MAPTHTTHRH3MEN1KMT2A | |
| SCHEMBL1453806 | 0.80 | MAPT (0.64) | MAPTHTTMEN1KMT2AALDH1A1 | |
| SCHEMBL11518048 | 0.80 | MAPT (0.80) | MAPTHTTHRH3MEN1KMT2A | |
| SCHEMBL11520411 | 0.78 | MAPT (0.85) | MAPTHTTHRH3MEN1KMT2A | |
| SCHEMBL409332 | 0.78 | MAPT (0.76) | MAPTHTTHRH3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1662527-A | Pyrrolidinium derivatives as antagonists of M3 muscarinic receptors | ALMIRALL PRODESFARMA SA (CH) | 2005-08-31 | — | — | CN | claimed |
| CN-101445469-B | Inhibitors of histone deacetylase | METHYLGENE INC | 2013-02-13 | — | — | CN | disclosed |
| US-8163753-B2 | 2-(4-(4-(4-chlorophenyl)oxazol-2-yl)phenoxymethyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole; bactericide; excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2012-04-24 | — | — | US | disclosed |
| CN-101805309-A | Benzamide derivatives as histone deacetylase inhibitors | ASTRAZENECA AB | 2010-08-18 | — | — | CN | disclosed |
| CN-100548978-C | Pyrrolidinium derivatives as M3 muscarinic receptor antagonists | ALMIRALL PRODESFARMA SA (ES) | 2009-10-14 | — | — | CN | disclosed |
| CN-100497345-C | 2, 3-dihydro-6-nitroimidazolo [2,1-b] oxazole compounds for the treatment of tuberculosis | OTSUKA PHARMA CO LTD (JP) | 2009-06-10 | — | — | CN | disclosed |
| CN-101445469-A | Inhibitors of histone deacetylase | METHYLGENE INC (CA) | 2009-06-03 | — | — | CN | disclosed |
| EP-1678185-B1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMA CO LTD (JP) | 2008-10-08 | — | — | EP | disclosed |
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | OTSUKA PHAMACEUTICAL CO., LTD. (JP) | 2008-05-22 | — | — | US | disclosed |
| EP-1221440-B1 | Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators | OTSUKA PHARMA CO LTD (JP) | 2007-04-25 | — | — | EP | disclosed |
| EP-0725316-B1 | Electrophotographic photoreceptor | KONISHIROKU PHOTO IND (JP) | 1999-06-30 | — | — | EP | disclosed |
| US-5846679-A | Electrophotographic photoreceptor | KONICA CORPORATION (JP) | 1998-12-08 | — | — | US | disclosed |
| US-5800956-A | Electrophotographic photoreceptor with specific interlayer | KONICA CORPORATION (JP) | 1998-09-01 | — | — | US | disclosed |
| EP-0671663-B1 | Electrophotographic photoreceptor | KONISHIROKU PHOTO IND (JP) | 1998-08-12 | — | — | EP | disclosed |
| US-5716745-A | INTERLAYER COMPRISE AN ALKOXY METALLIC CHELATE COMPOUNDS OF TITANIUM OR ALUMINUM HAVING A CHELATE GROUP OF ACETOACETIC ESTER OR DIKETONE AND AN ORGANOSILANE COMPOUND HAVING AT END A METHACRYLOXY OR AMINO GROUP; EXPOSURE, REVERSE DEVELOPMENT | KONICA CORPORATION (JP) | 1998-02-10 | — | — | US | disclosed |
| EP-0765314-A1 | BENZOHETEROCYCLIC DERIVATIVES USEFUL AS VASOPRESSIN OR OXYTOCIN MODULATORS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1997-04-02 | — | — | EP | disclosed |
| EP-0763782-A1 | Electrophotographic photoreceptor | KONICA CORPORATION (JP) | 1997-03-19 | — | — | EP | disclosed |
| EP-0725316-A1 | Electrophotographic photoreceptor | KONICA CORPORATION (JP) | 1996-08-07 | — | — | EP | disclosed |
| WO-1995034540-A1 | BENZOHETEROCYCLIC DERIVATIVES USEFUL AS VASOPRESSIN OR OXYTOCIN MODULATORS | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1995-12-21 | — | — | WO | disclosed |
| EP-0671663-A1 | Electrophotographic photoreceptor | KONICA CORPORATION (JP) | 1995-09-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | NR2C2, NR0B2, NR4A2 | MAPT 4299/4885HTT 4689/4885HRH3 538/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.